KEVZARA
Live / Registered — Registered — Section 8 accepted (as of 29 Nov 2023)
What this means for you
Registered since 29 Aug 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87275074
- Registration number
- 5274968
- Mark type
- Design + words
- Filed
- 20 Dec 2016
- Published for opposition
- 13 Jun 2017
- Registered
- 29 Aug 2017
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical product for the treatment of autoimmune diseases, inflammatory diseases, rheumatoid arthritis, and ankylosing spondylarthritis
Owner
- Sanofi Biotechnology, Paris, FR
- Sanofi Biotechnology, 75008 Paris, FR
- Sanofi Biotechnology, 75008 Paris, FR
Prosecution history
- 29 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 29 Nov 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 29 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Aug 2023 — TEAS SECTION 8 RECEIVED
- 29 Aug 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Aug 2017 — REGISTERED-PRINCIPAL REGISTER
- 13 Jun 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jun 2017 — PUBLISHED FOR OPPOSITION
- 24 May 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 May 2017 — ELECTRONIC RECORD REVIEW COMPLETE
- 05 May 2017 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 26 Apr 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Apr 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED